This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CIT Group (CIT) Q3 Earnings Meet Estimates, Stock Falls 1.2%
by Zacks Equity Research
Decline in expenses and rise in non-interest income support CIT Group's (CIT) Q3 earnings, while higher credit costs and a fall in interest income hurt.
Jefferies (JEF) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Jefferies (JEF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Jefferies (JEF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Leucadia National Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Leucadia National has been struggling lately, but the selling pressure may be coming to an end soon.
Why Jefferies (JEF) is Such a Great Value Stock Pick Right Now
by Zacks Equity Research
Jefferies (JEF) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Top Ranked Momentum Stocks to Buy for August 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 20th:
Is Jefferies (JEF) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Jefferies (JEF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Momentum Stocks to Buy for August 15th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 15th:
Here's Why You Should Add MoneyGram (MGI) to Your Portfolio
by Zacks Equity Research
Investments in several growth areas position MoneyGram (MGI) for long-term growth.
Jefferies (JEF) Q2 Earnings Miss Estimates
by Zacks Equity Research
Jefferies (JEF) delivered earnings and revenue surprises of -95.74% and 15.38%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: CME Group, Discover Financial Services, Leucadia National and Houlihan Lokey
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CME Group, Discover Financial Services, Leucadia National and Houlihan Lokey
Finance Stocks Jul 26 Q2 Earnings Roster: CME, DFS, JEF, HLI
by Zacks Equity Research
Rising interest rates and lowered tax incidence should drive the finance sector's second-quarter performance.
Leucadia National Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Leucadia National Sees Hammer Chart Pattern: Time to Buy?
MoneyGram Renews Ties With UK Post Office to Expand Services
by Zacks Equity Research
MoneyGram (MGI) expands partnership with Post Office to provide customers with money transfer services in multiple UK Post Office locations.
Leucadia National (JEF): An Off-the-Radar Potential Winner
by Zacks Equity Research
Although overlooked by the investors, Leucadia National (JEF) looks well-positioned for a solid gain, supported by a favorable Zacks rank and positive estimate revisions.
Looking for Value? Why It Might Be Time to Try Jefferies (JEF)
by Zacks Equity Research
Jefferies (JEF) seems to be a good value pick, with solid earnings estimate revisions.
Should You Get Rid of Leucadia National (JEF) Now?
by Zacks Equity Research
Leucadia National (JEF) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.